Instrument Inactif

Autres langues HemaCare Corporation OTC Bulletin Board

Actions

Installations et services en soins de santé

Autres langues

02/06/20	HemaCare Corporation Adds GMPrime Cryopreserved Leukopak to its GMP Product Portfolio
21/01/20	MicroMedicine and HemaCare Announces Cooperative Efforts to Improve Cell Therapy Starting Materials
03/01/20	Charles River Laboratories International, Inc. completed the acquisition of HemaCare Corporation.
16/12/19	HEMACARE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of HEMA and Encourages Investors to Contact the Firm
16/12/19	Charles River Laboratories International, Inc. entered into a definitive agreement to acquire HemaCare Corporation for approximately $380 million.
19/11/19	HemaCare Expands Its Product Portfolio with GMPrime™ Bone Marrow Aspirate
27/08/19	HemaCare Corporation and Vital River Partner to Provide Human-Derived Biological Material to China
20/08/19	Hemacare Corporation Reports Earnings Results for the Half Year Ended June 30, 2019
26/03/19	HemaCare Corporation Reports Earnings Results for the Year Ended December 31, 2018
20/12/18	HemaCare Corporation announced that it has received $4.999999 million in funding from OBF Investments LLP
06/12/18	HemaCare Corporation Moves its Global Headquarters to Northridge, California
14/11/18	HemaCare Corporation Provides Starting Material for Three FDA Approved Cellular Therapies
21/08/18	HemaCare Corporation Reports Unaudited Earnings Results for the Six Months Ended June 30, 2018
17/07/18	HemaCare Corporation Announces Executive Appointments
08/03/18	HemaCare Corporation Reports Earnings Results for the Full Year Ended December 31, 2017
06/02/18	HemaCare Corporation and Charles River Laboratories International Inc. Announces Strategic Partnership to Accelerate Drug Discovery and Development
21/08/17	HemaCare Corporation Reports Unaudited Earnings Results for the First Six Months Ended June 30, 2017
24/07/17	HemaCare Signs Long Term Lease for Facility Relocation and Expansion
13/03/17	HemaCare Corporation Reports Financial Results for the Year Ended December 31, 2016
20/02/17	HemaCare Corporation Signs Distribution Agreement with Almog Diagnostic
06/01/17	HemaCare Corporation announced that it expects to receive $5 million in funding from OBF Investments LLP
31/10/16	HemaCare Signs Distribution Agreement with Accuresearch Korea, Inc
06/09/16	HemaCare Corp. Reports Unaudited Earnings Results for the First Six Months Ended June 30, 2016
12/05/16	HemaCare Corporation Signs Strategic Distribution Agreement with MT-Biological Science and Technology Co. Ltd
28/03/16	HemaCare Corp. Expands its Offering of Stem Cell-Enriched Peripheral Blood